MELODY TRANSCATHETER PULMONARY VALVE (TPV), ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)

Pulmonary Valve Prosthesis Percutaneously Delivered

FDA Premarket Approval P140017

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval the melody transcatheter pulmonary valve (tpv) and the ensemble transcatheter valve deliverysystem. This device is indicated for use as an adjunct to surgery in the management of pediatric and adult patients with the following clinical conditions:1) existence of a full (circumferential) right ventricular outflow tract (rvot) conduit that was equal to or greater than 16 mm in diameter when originally implanted, and 2) dysfunctional rvot conduit with a clinical indication for intervention, and: a) regurgitation >= moderate regurgitation, and/or b) stenosis: mean rvot gradient >= mmhg.

DeviceMELODY TRANSCATHETER PULMONARY VALVE (TPV), ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
Classification NamePulmonary Valve Prosthesis Percutaneously Delivered
Generic NamePulmonary Valve Prosthesis Percutaneously Delivered
ApplicantMEDTRONIC Inc.
Date Received2014-08-21
Decision Date2015-01-27
Notice Date2015-01-27
PMAP140017
SupplementS
Product CodeNPV
Docket Number15M-0266
Advisory CommitteeCardiovascular
Expedited ReviewYes
Combination Product No
Applicant Address MEDTRONIC Inc. 8200 Coral Sea Street Ne mvs83 mounds View, MN 55112
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140017Original Filing
S023 2022-11-16 30-day Notice
S022 2022-07-20 30-day Notice
S021 2022-02-28 30-day Notice
S020 2022-01-27 30-day Notice
S019 2021-07-29 30-day Notice
S018
S017 2019-10-01 30-day Notice
S016
S015 2019-06-20 30-day Notice
S014 2018-11-13 Normal 180 Day Track No User Fee
S013
S012 2018-10-01 30-day Notice
S011 2018-09-26 Real-time Process
S010 2017-12-01 30-day Notice
S009
S008 2017-09-11 30-day Notice
S007 2017-04-19 30-day Notice
S006 2016-11-23 Normal 180 Day Track No User Fee
S005 2016-09-01 Panel Track
S004 2016-04-25 Normal 180 Day Track
S003 2016-04-08 30-day Notice
S002 2016-03-23 30-day Notice
S001 2015-06-17 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00643169588455 P140017 000
00643169588448 P140017 000
00643169588431 P140017 000
00643169588196 P140017 000
00643169588189 P140017 000
00643169713895 P140017 004
00643169713901 P140017 004
00643169713888 P140017 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.